Drug · DIN 02477939
AG-GABAPENTIN
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 22, 2024; first marketed September 28, 2018.
- Drug Identification Number (DIN)
- 02477939
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- April 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 22, 2024: NOC 33687Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
- June 27, 2018: NOC 21026Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named AG-GABAPENTIN
- DIN 02477912 · Dormant
- DIN 02477920 · Dormant